A multicenter, randomized, double-blind, crossover study of patient preference for tadalafil 20 mg or sildenafil citrate 50 mg during initiation of treatment for erectile dysfunction

Author: Govier F.   Potempa A.-J.   Kaufman J.   Denne J.   Kovalenko P.   Ahuja S.  

Publisher: Elsevier

ISSN: 0149-2918

Source: Clinical Therapeutics, Vol.25, Iss.11, 2003-11, pp. : 2709-2723

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content